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Abstract 
Background  
Residential Medication Management Reviews (RMMRs) are routinely conducted in 
Australian residential aged care facilities (ACFs) to improve medication outcomes 
in elderly residents. Medication regimen complexity has been associated with poor 
patient outcomes. However, little is known about the impact of medication 
reviews on medication regimen complexity in older people living in ACFs.  
 
Objectives 
The primary objective of this study was to investigate the impact of RMMRs on 
medication regimen complexity, as assessed by a validated measure. 
 
Methods 
Retrospective analysis of RMMRs pertaining to 285 aged care residents aged ≥65 
years in Sydney, Australia. Medication regimen complexity was measured using 
the Medication Regimen Complexity Index (MRCI) at baseline, after pharmacists’ 
recommendations (assuming that all of the pharmacists’ recommendations were 
accepted by the General Practitioner (GP)), and after the actual uptake of 
pharmacists’ recommendations by the GP. Differences in the regimen complexity 
was measured using the Wilcoxon sign rank test.  
 
Results 
Pharmacists made 764 recommendations (average 2.7 recommendations per 
RMMR), of which 569 (74.5%) were accepted by GPs.  The median MRCI at 
baseline in the sample was 25.5 (IQR= 19.0-32.5). No statistically significant 
differences were demonstrated in the MRCI scores after pharmacists’ 
recommendations (P=0.53) or after GPs’ acceptance of these recommendations 
(p=0.07) compared to the baseline. 
 
Conclusion  
Our study revealed high acceptance of pharmacists’ recommendations by GPs. 
This suggests that RMMRs are useful for identifying and resolving drug-related 
issues among residents of ACFs. However, our study failed to show a significant 
effect of RMMRs in reducing the medication regimen complexity, as measured by 
the MRCI. Further studies are needed to establish the association of medication 
regimen complexity and clinical outcomes in residents of ACFs. 
 
  
Introduction  
Older people (≥65 years) are accounting for an increasing share of the population 
worldwide [1], and Australia is no exception. In 2013, 14% of the Australian 
population were aged ≥65 years and 1.9% were aged ≥85 years. This proportion 
is projected to increase to approximately 21% and 4.2%, respectively, by 2053. 
Such an increase in the aging population brings major challenges to the health 
care system as older people have higher health care utilization and associated 
costs [2]. 
 
The number of health conditions is higher in older age groups and, consequently, 
this population are prescribed a large number of medications [3]. Prescribing in 
older people is complex because of the age-related changes in body composition 
and multiple pathologies [4, 5]. In older people with multiple comorbidities, 
prescribing must be balanced between limiting the number of medications and 
using all medications that may be beneficial [6]. Previous studies have reported 
that residents of aged-care facilities (ACFs) are prescribed significantly more 
medications than people living in the community [7]. Over 90% of the residents 
of ACFs are subject to polypharmacy, defined as the concomitant use of 5 or more 
drugs, with a reported average of 9.75 medicines per resident [8]. 
 
In general, as the number of medications increase, the medication regimen 
becomes more complex. However, it is important to note that the number of 
medications taken by a patient is only one element of regimen complexity. Other 
elements that are associated with regimen complexity include dosage forms, 
dosing frequencies, and specific dosing instructions [9]. Previous studies have 
associated high medication regimen complexity with lower medication adherence 
[10, 11] and an increased risk of hospital readmission [12]. While medication 
adherence is less problematic in this environment, measuring the complexity of 
medication regimen is an important aspect of the care of ACF residents as it may 
add to staff workloads and these residents are reported to have a generally high 
medication regimen complexity [13, 14]. 
 
In Australia, Residential Medication Management Reviews (RMMRs) are a 
nationally remunerated service available to all permanent residents of 
government funded ACFs. The RMMR service is a key strategy for achieving 
quality use of medicines and involves an accredited pharmacist, who has access 
to clinical data, medication lists and diagnoses, visiting the resident and assessing 
the resident’s medications to identify medication-related issues. The accredited 
pharmacist then makes recommendations to the resident’s physician to resolve 
any medication-related issues [15]. Although previous studies have shown that 
medication reviews performed by pharmacists can improve medication use by 
identifying and resolving drug-related problems in residents of ACFs [16, 17], 
there is limited evidence of the impact of RMMRs on simplifying medication 
regimens.  
 
The aim of this study was to investigate the impact of RMMR on simplifying 
medication regimen complexity in Australian ACF residents by using the 
Medication Regimen Complexity Index (MRCI). The specific objectives of this 
study were to: 1) determine the MRCI scores in older people living in ACFs; 2) 
evaluate the potential impact of recommendations made by accredited 
pharmacists on MRCI scores; and 3) evaluate the impact of the RMMR services 
on MRCI scores after general practitioner (GP) uptake of pharmacists’ 
recommendations.  
 
2 Methods  
 
2.1 Ethics and Study Population  
 
This was a retrospective study of de-identified RMMR reports with GP outcomes 
pertaining to 285 residents living in residential ACFs in Australia. The RMMR 
reports were collected from a single RMMR service provider (Meditrax, Sydney, 
New South Wales, Australia) and were conducted between August 2011 and 
December 2012. Accredited pharmacists compiled RMMR reports, which included 
a comprehensive medication history, current medical diagnoses, actual 
medications taken, clinical pathology results, pharmacists’ findings and 
recommendations. GP feedback on the RMMR reports and reconciled medication 
charts for each resident determined whether pharmacists’ recommendations to 
resolve any problems were accepted or not. Due to the de-identified nature of 
data collected, the study was exempted by the local Human Research Ethics 
Committee. 
 
2.2 Data Collection and Analysis 
 
A comprehensive review of the RMMR reports conducted by accredited 
pharmacists was performed by one study investigator (MP). A standardized pro 
forma was developed in Microsoft Excel to aid data collection. The data extracted 
included patient demographics, diagnosed medical conditions, current medication 
profile, pharmacists’ recommendations, and GPs’ acceptance of pharmacists’ 
recommendations. All medications and diagnoses were coded as per the 
Anatomical Therapeutic Chemical (ATC) classification system [18] and the 
International Classification of Disease, 10th revision (ICD-10) [19], respectively. 
 
2.3 Medication Assessment 
 
Each resident’s medication regimen complexity was computed using the 65-item 
validated MRCI, developed by George et al. [9]. The MRCI provides scores for 
dosage forms, dosing frequencies, and additional directions. Higher MRCI scores 
reflect more complex regimens. Both the prescribed and over-the-counter 
medications taken by the residents were reviewed and scored based on the MRCI.  
The MRCI scores were determined at three different time points: at baseline, 
post-RMMR (with the assumption that all of the pharmacists’ recommendations 
were taken up by the GPs), and post-GP actual uptake of the pharmacists’ 
recommendations.  
 
2.4 Recommendation Assessment Criteria  
 
The accredited pharmacists’ recommendations were categorised as those that: 
(i)  Decreased the MRCI score. 
(ii) Increased the MRCI score. 
(iii)  Did not change the MRCI score. 
 
2.5 Statistical Analysis  
 
Data was analysed using Microsoft Excel and IBM SPSS Statistics for Windows, 
Version 20.0 (Armok. NY: IBMCrop). A total number of 285 residents’ MRCI scores 
were computed at baseline, post-RMMR, and post-GP uptake of pharmacists’ 
recommendations. 
 
The change in MRCI score before and after the RMMR, (i) assuming that all of the 
pharmacists’ recommendations were accepted by the GPs and (ii) based on the 
actual GP acceptance of pharmacists’ recommendations, were compared using 2-
tailed Wilcoxon signed rank tests (P<0.05). 
 
3 Results 
  
Table 1 presents the baseline characteristics of the residents. The mean (standard 
deviation (SD)) age was 85.5 (7.7) years and 68% (n=193) of the residents were 
female.  At baseline, the mean (SD) number of medical conditions was 6.8 (2.6) 
and the mean (SD) number of medications was 8.8 (3.3). Diseases of the 
circulatory system were the most common medical conditions (n=389, 20.2%) 
and the most frequently prescribed class of medication was that pertaining to the 
nervous system (n=706, 28.2%).  
 
3.1 Medication Regimen Complexity Index 
 
The median MRCI (interquartile range (IQR)) at baseline in the study sample was 
25.5 (19.0-32.5). The main contributing factor to the MRCI score was dosing 
frequency with a median (IQR) of 12.0 (8.5-16.0), followed by additional 
directions 8.0 (5.0-10.0), and dosage forms 5.0 (3.0-8.0). The most prevalent 
dosing frequency for all medications was once daily dosing (1348 medications, 
53.8%), the most prevalent dosage form was oral (2069 medications, 83.8%), 
followed by topical (127 medications, 5.1%), and the most prevalent additional 
direction was to take at specific time/s (1129 medications, 51%). Table 2 shows 
the sections of the MRCI and the median values.  
 
Overall, there were no significant differences in the MRCI scores after 
pharmacists’ recommendations (P=0.53) or after GPs’ acceptance of these 
recommendations (p=0.07) compared to the baseline MRCI scores (Table 2). The 
almost statistically significant latter finding indicated a trend towards GPs 
implementing more suggested changes that did reduce the medication 
complexity. A further breakdown of the MRCI scores show that for section A 
(Dosage forms) pharmacists’ recommendations during the RMMR and following 
GPs’ acceptance of the recommendations resulted in a significant increase, whilst 
section C (Additional directions) showed a significant decrease following 
pharmacists’ recommendations and GPs’ acceptance of the recommendations 
(p<0.001). 
 
3.2 Number and types of recommendations 
 
Pharmacists made a total number of 764 recommendations (average 2.7 
recommendations per RMMR), 74.5% (n=569) of which were accepted by GPs. 
Overall, 29% (n=222) of pharmacists’ recommendations resulted in an increase 
in the MRCI score whilst 30% (n=229) resulted in a decrease in the MRCI score. 
A total of 313 (41%) recommendations did not affect MRCI score. These latter 
recommendations pertained to monitoring of laboratory or clinical indices, such 
as blood pressure. 
 
4 Discussion  
 
To our knowledge, this is the first study that has evaluated the impact of RMMRs 
on simplifying medication regimen complexity in Australian ACF residents by using 
the MRCI. The results of our study showed that although nearly three-quarters 
(74.5%) of the recommendations made by the pharmacists were accepted by the 
GPs, no significant reduction in the complexity of medication regimens resulted 
from pharmacists’ recommendations and GP uptake of these recommendations.  
 
Our study found that only 30% of the pharmacists’ recommendations reduced the 
MRCI score. Review of the RMMR reports showed that the pharmacists’ 
recommendations were justifiably often directed towards dose optimisation, 
reduction of side effects, monitoring for drug complications, patients’ physical 
ability to take medications and ways to ease medication consumption. However, 
these recommendations did not necessarily reduce the MRCI score. For example, 
the suggestion to change vitamin D tablet once daily to vitamin D liquid once 
weekly, may seem to make it easier for the patient to take the medication but 
actually increases MRCI score by 2 points as a result of changing the tablet 
(score=1) to liquid (score=2) form and the frequency from once daily (score=1) 
to a less frequent (score=2) once weekly regimen. Furthermore, in ACFs, nurses 
are generally responsible for administering medications to the residents and the 
pharmacists may thus not see the value in reducing the medication regimen 
complexity for these patients. The importance of reducing complexity may also 
have been underestimated by pharmacists for patients who used dose 
administration aids (DAAs). A study by Elliot et al. [20] showed that pharmacists 
did not simplify medication regimen complexity for patients who were discharged 
to an ACF or using a DAA after discharge. When medication regimens are 
simplified, less time is spent for administration of medications by nurses and the 
prevalence of medication errors is lowered [14]. Thus, it is important for the 
pharmacist to be mindful of the significance of simplifying medication 
administration when conducting RMMRs by being aware of medication regimen 
complexity. 
 
Factors that can reduce medication regimen complexity include use of 
combination medications, long-acting formulations as an alternative to multiple 
daily dosing, lower strength doses instead of splitting of tablets [22], or the 
deprescribing of preventative medications such as statins, bisphosphonates 
wherever relevant [23, 24]. We suggest further education of pharmacists to 
enhance understanding of these factors. The importance of pharmacist training 
regarding medication regimen simplification has also been suggested by Advinha 
et al. [13]. A study by Elliott [24] showed that it was feasible to achieve the goal 
of medication regimen simplification by training pharmacists and this could be 
greatly enhanced with doctors’ cooperation. Education of doctors in conjunction 
with pharmacists was significant as it was found that 63% of the recommended 
changes to reduce medication regimen complexity were successfully 
implemented. Further studies examining the effectiveness of educational modules 
for pharmacists and GPs in reducing medication regimen complexity and achieving 
associated clinical outcomes following RMMRs in ACFs are warranted. 
 
The mean (SD) baseline MRCI in our study was 26.0 (9.8). This figure was higher 
compared to a previous study conducted on institutionalized elderly people which 
had a mean (SD) MRCI of 18.2 (9.6) [13]. In contrast, the median MRCI (43.5) 
of the study by Herson et al. [14] on residents of long-term ACFs was significantly 
higher than our study (25.5). In the study by Herson et al. [14], the proportion 
of diseases (e.g. cardiovascular system and diabetes) requiring combinations of 
different treatments and using medications with high MRCI score (e.g. prefilled 
injection has a score of 3) was significantly higher than our study. The mean (SD) 
MRCI score for elderly discharged from hospital was reported as 30.3 (14.0) [10]. 
The score could be higher because recently discharged people often were 
diagnosed with new conditions and prescribed new medications. The mean (SD) 
MRCI score of elderly patients in older home care patients was 35.4 (22.4) [25], 
considerably higher than our results. This could be related to the higher number 
of prescribed medications than our study, as the number of medications is one of 
the components of MRCI.  
 
In agreement with our results, Advinha et al. [13] found that dose frequency was 
the main contributor in increasing the MRCI score. Our study showed an increase 
in the section B score after pharmacists’ recommendations and after GP uptake 
of recommendations, however this did not reach statistical significance. Herson 
et al. [14] showed that once daily dosing was the most frequent dosing frequency 
(54.6%) which was consistent with our results (53.8%). In our study the most 
prevalent dosage form was oral forms (83.8%), followed by topical forms (5.1%) 
which were in line with the findings of Advinha et al. [13] - oral forms (90.5%) 
and topical forms (4.1%) and Herson et al. [14] - oral tablet/capsules (70.4%) 
and topical creams, gels, paints and patches (8.6%). The higher percentage of 
oral forms in our study in comparison with Herson et al. [14] could be explained 
by the inclusion of other oral dosage forms in addition to tablets/capsules (liquids, 
lozenges, or powders/sachets) in our study.  
 
In Australian ACFs, inappropriate prescribing is not uncommon [26]. The RMMR 
was designed to enhance the quality use of medicines and reduce ADEs for 
permanent residents of Australian ACFs [15]. A recent Australian literature review 
showed that pharmacists were concentrating on many aspects of medication 
management during medication reviews such as compliance, inappropriate drug 
selection, and additional monitoring to detect or prevent adverse reactions [27].  
A successful reduction in prescribing of sedative and anticholinergic medications 
was reported following pharmacist conducted RMMRs [28] and a retrospective 
study involving 62 ACFs revealed that RMMRs were able to identify over 96% of 
drug related problems in the residents [16]. In our study, pharmacists made a 
total of 764 recommendations by conducting RMMRs. Although these may not 
have necessarily reduced medication regimen complexity, the fact that the 
majority of these were accepted by GPs suggested that the recommendations 
were appropriate in improving the residents’ quality of life by addressing potential 
drug-related problems. 
 
4.1 Limitations 
 
This was a retrospective study and although GPs noted that they would consider 
some recommendations pending other factors such as laboratory results, it is 
unknown to what extent these recommendations had been implemented by GPs, 
resulting in further change in MRCI.   
 
Additionally, the RMMR data collected was performed by accredited pharmacists, 
all of whom were associated with one RMMR service provider, and the results 
may not be generalised to other RMMR service providers and accredited 
pharmacists nationally. Finally, similar to the study by Herson el at. [14], our 
study also used an MRCI tool which has not been validated for use in ACFs. 
 
5 Conclusion 
 
Accredited pharmacists can use the MRCI to identify older people with complex 
medication regimens. Our study failed to show significant benefit of RMMRs in 
reducing the medication regimen complexity as measured by the MRCI. Further 
studies are needed to establish the association of MRCI and clinical outcomes in 
residents of ACFs. However, the study revealed that RMMRs are useful for 
identifying and resolving drug-related issues among residents of ACFs. 
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 Table 1 Baseline characteristics of the study sample (n=285) 
Characteristics Value 
Age, Y, Mean (SD)  85.6 (7.7) 
Sex, n (%) 
  Female 
  Male  
 
193(67.7) 
92(32.3) 
Medical conditions per patient [mean (SD)] 
 Top 5 medical conditions [number (%)] 
   Diseases of the circulatory system  
   Mental and behavioural disorders  
   Diseases of the musculoskeletal system and connective tissue 
   Endocrine, nutritional and metabolic diseases 
   Diseases of the nervous system  
6.8(2.6) 
 
389(20.2) 
299(15.5) 
241(12.5) 
148(7.7) 
124(6.5) 
Medications per patient [mean (SD)] 
Regular prescription medication, [mean (SD)] 
“When required” medications [mean (SD)] 
   Top five medication classes [number (%)] 
     Nervous system 
     Alimentary tract and metabolism 
     Cardiovascular system 
     Blood and blood forming organs  
     Sensory organs  
8.8 (3.3) 
7.2 (2.9) 
1.6(1.4) 
 
706(28.2) 
686(27.4) 
448(17.9) 
208(8.3) 
107(4.3) 
 Table 2 Medication Regimen Complexity Index score at baseline, post-RMMRs, and after GPs’ considerations of pharmacist’s 
recommendations 
MRCI 
score 
Median 
(IQR) 
Mean (SD) MRCI 
score 
Median 
(IQR) 
Mean (SD) P-value MRCI 
score 
Median 
(IQR) 
Mean (SD) P-value 
MRCI 
score 
baseline 
25.5 
(19.0-32.5) 
26.0(9.8) MRCI 
score 
post-
RMMRs 
25.0 
(19.0-33.5) 
25.9 (9.7) 0.526 MRCI 
score 
post-GP 
uptake 
25.0 
(19.0-33.0) 
25.8  (9.7) 0.069 
Section-A 
Dosage 
Forms 
MRCI score 
baseline 
5.0  
(3.0-8.0) 
5.7 (4.0) Section-A 
Dosage 
Forms 
MRCI score 
post-
RMMRs 
5.0 
(3.0-8.0) 
6.1 (4.1) <0.001* Section-A 
Dosage 
Forms 
MRCI score 
post-GP 
uptake 
5.0  
(3.0-8.0) 
5.8  (4.0) 0.024* 
Section-B 
Dosing 
Frequency 
MRCI score 
baseline 
12.0  
(8.5-16.0) 
12.4(5.0) Section-B 
Dosing 
Frequency 
MRCI score 
post-
RMMRs 
12.5 
 (9.0-15.7) 
12.4  (4.8) 0.694 Section-B 
Dosing 
Frequency 
MRCI score 
post-GP 
uptake 
12.5  
(8.7-15.5) 
12.4  (4.9) 0.385 
Section-C 
Additional  
Directions 
MRCI score 
baseline 
8.0 
(5.0-10.0) 
7.9 (3.5) Section-C 
Additional 
Directions 
MRCI score 
post-
RMMRs 
7.0  
(5.0-10.0) 
7.4 (3.3) <0.001* Section-C 
Additional 
Directions 
MRCI score 
post-GP 
uptake 
7.0  
(5.0-10.0) 
7.6 (3.4) <0.001* 
*Significant at P<0.05 
 
